Document is current
Any future updates will be listed below
-
Authors
Vaena, Mariana
Aguirre, María Adela
Epstein, Teo
Schalum, Agustín
Hilbert, Facundo Ezequiel
Posadas-Martínez, María Lourdes
Carretero, Marcelina https://orcid.org/0000-0003-2259-5626
-
Funding
Funding for this research was provided by:
Pfizer LATAM (88792339, 88792339, 88792339)
- License Information
-
More Information
Article History
Received: 5 March 2025
Accepted: 31 July 2025
First Online: 19 August 2025
Declarations
:
: The authors declare no competing interests.
: This study protocol relied on a limited, secondary data set and was approved by the Comité de Ética de Protocolos de Investigación of the Hospital Italiano de Buenos Aires (IRB) under number 7980, which waived the requirement for informed consent. This research was conducted in compliance with ethical principles consistent with national and international regulatory standards for human health research, in accordance with National Ministerial Resolution No. 1480/2011, Law 3301/09 of the Ciudad Autónoma de Buenos Aires, the Declaration of Helsinki, and in compliance with ICH E6 Good Clinical Practice Standards. This study is retrospective in nature, and the requirement for informed consent was waived by the Comité de Ética de Protocolos de Investigación of the Hospital Italiano de Buenos Aires in accordance with the relevant guidelines and regulations.
